55

 

Nanostructed Sensing Devices for Biomedical Applications--AMSEN Technologies, 1684 South Research Loop, Suite 518, Tucson, AZ  85710; 520-546-6944

Dr. Chuanjing Xu, Principal Investigator

Dr. Ayyasamy Aruchamy, Business Official

DOE Grant No. DE-FG03-00ER82944

Amount:  $100,000

 

Rapid assessment of toxicological drugs is needed for the prevention, diagnosis, and treatment of disease and for improving human health.  Existing sensor technologies have inherent limitations that are not suitable for such applications.  This research program seeks to develop nanostructured sensing devices that can be significantly smaller and faster, more sensitive and reliable than existing sensors.  We seek to accomplish this by preparing sensors using emerging micro-and nano-technologies that can provide nano-engineered sensor structure and corresponding advantages of nanoscopic phenomena.  The Phase I research work will include synthesis, processing, and characterization of nano-ring electrode ensembles; fabricating nanostructured electrochemical biosensors; and testing the sensor performance.  During Phase I, AMSEN Technologies will demonstrate the proof-of-concept of such a sensor, and build the foundation for Phase II optimization, prototyping, and commercialization.

 

Commercial Applications and Other Benefits as described by the awardee:  The proposed sensor technology will lead to fast and sensitive response to important biomedical precursors, and therefore will solve problems associated with real-time and highly sensitive detection of toxicological drugs under emergency conditions.  Healthcare and medical industry, environmental monitoring and on-line monitoring and control of chemical or pharmaceutical industry processing can be expected to benefit from the proposed sensor technology.